Project Details
Description
A 12 month, multi-center randomized, open-label non-inferiority study of efficacy and safety comparing concentration-controlled Everolimus with low dose tacrolimus to Cellcept with standard dose tacrolimus in de novo renal tranplant recipients
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/09 → 5/11/13 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.